Emerson’s miss is less about demand than mix: software renewal math is masking a cleaner 2026 margin setup

The print should be read as a mix and cadence reset, not as a broken automation cycle. EMERSON ELECTRIC CO reported EPS of $1.62 against the Street’s $1.62, a 0.0% surprise, while revenue of $4,855.0 million missed the $4,900.2 million estimate by -0.9%. That separation matters: the buy side came in expecting revenue to clear a low bar after Q3 FY2025 revenue of $4,553.0 million and Q4 FY2025 sequential growth of +6.6%, but the company still held the EPS line. The market may therefore be treating the top-line miss as a demand signal when the more investable signal is that gross margin held at 51.9% in Q4 FY2025 despite the miss, after 52.6% in Q3 FY2025 and 51.3% in Q4 FY2024. The quarter did not prove Emerson can grow without friction; it proved that the current portfolio can absorb geography and renewal noise without losing the earnings algorithm.

That distinction is sharper because what was priced in and what surprised were different things. Priced in was a quarter that would validate the post-portfolio-transformation story with revenue at $4,900.2 million, EPS at $1.62, and a continuation of recent gross margin levels that had run 53.5% in Q1 FY2025, 53.5% in Q2 FY2025, and 52.6% in Q3 FY2025. The actual surprise was not EPS, where the print was exactly $1.62, but the revenue miss of -0.9% and the gross margin step to 51.9%. That mix can look like deceleration if investors stop at the headline. The counter is that Q4 FY2025 revenue still grew +5.1% year-over-year and +6.6% quarter-over-quarter, while the company’s own full-year commentary conceded the soft spots rather than hiding them. Surendralal Karsanbhai’s phrasing is useful because it names the issue: “For the full year, underlying sales grew 3%, slightly below expectations as Europe and China were softer than initially expected.” The relevance of that quote is not the 3% itself; it is that management isolated the shortfall in Europe and China, leaving the power, LNG, life sciences, semiconductor, and aerospace and defense funnel intact.

The financial trajectory supports that interpretation because the revenue line has been uneven while the margin base has been structurally higher than the pre-2024 period. Revenue moved from $3,756.0 million in Q2 FY2023 to $4,855.0 million in Q4 FY2025, but the more important transition is gross margin from 47.9% in Q2 FY2023 to 51.9% in Q4 FY2025, with recent quarterly levels consistently above 51.3% since Q4 FY2024. The revenue path includes normal seasonality, including Q1 FY2025 revenue down -9.6% quarter-over-quarter and the forward Q1 FY2026 line at $4,346.0 million, down -10.5% quarter-over-quarter, so the sequential drop embedded after Q4 should not be overread as a new demand break. The relevant question is whether 2026 margin can hold when the software renewal year becomes less favorable. Management has already answered with a bridge that separates a known $120 million full-year software renewal headwind from operating expansion, rather than letting investors assume the two are the same phenomenon.

The capacity story explains the margin guide, because Emerson’s 2026 algorithm is less dependent on broad industrial acceleration than on specific end-market funnels and internal cost takeout. Michael Baughman said growth should come from power, LNG, life sciences, semiconductor, and aerospace and defense markets, which together comprise approximately $6 billion of the $11.1 billion large project funnel. That is the number that matters for semiconductor investors: the company’s Test & Measurement segment is planned to have high single-digit growth in both the first half and full year, while Control Systems & Software is expected to be down low single digits in the first half due to a $110 million headwind from a lower value of software contracts up for renewal in 2026. For the full year, that headwind is projected to be $120 million. This is the crux of the variant perception: investors screening the first-half Control Systems & Software decline may see product weakness, but management is telling us the discrete renewal pool is subtracting $110 million in the first half and $120 million for the year, while Test & Measurement is still planned for high single-digit growth.

The EPS bridge makes the same point in per-share terms, and it is where the market’s likely mispricing becomes actionable. Management guided 2026 adjusted earnings per share of $6.35 to $6.55, while also saying adjusted segment EBITDA margin should be approximately 28%. In the first quarter, the company expects adjusted earnings per share of approximately $1.40 and adjusted segment EBITDA margin of approximately 27%. The near-term setup includes a $0.07 impact from the software contract renewal dynamic, offset by EPS contributions from operations of about $0.05 and nonoperating items of approximately $0.04. For the full year, the renewal dynamic reduces adjusted EPS by approximately $0.15 and adjusted segment EBITDA margin by approximately 40 basis points, while operations are expected to generate about $0.50 of incremental EPS in 2026 with approximately 80 basis points of margin expansion from positive price/cost and synergies. The quality of the guide is therefore better than the top-line miss implies: the company is eating a quantified renewal drag and still pointing to operations that add about $0.50 of EPS.

That operating bridge is more credible because the synergies are no longer a long-dated promise. Karsanbhai said Emerson realized $50 million of synergies in 2025 and now plans to achieve $100 million in run rate synergies by the end of 2026, “2 years ahead of plan.” That last phrase earns attention because it compresses the time line for margin self-help into the same fiscal year that bears the $120 million software renewal headwind. Baughman’s margin detail adds a second check: adjusted segment EBITDA margin of 27.6% exceeded expectations and was up 160 basis points year-over-year, with 50 basis points from a favorable software contract renewal year in 2025 and the remaining 110 basis points from positive price cost, cost reductions, and Test & Measurement and AspenTech acquisition synergies, offsetting inflation and tariffs. The number to underwrite is not the 50 basis points that rolls off; it is the 110 basis points already visible from operating levers, plus the approximately 80 basis points management expects in 2026 from price/cost and continued synergy realization.

The cash return plan reinforces that management is not treating the revenue miss as the start of a cash squeeze. Emerson generated $3.24 billion in free cash flow, above August guidance of $3.2 billion and consistent with initial guidance while absorbing approximately $200 million of acquisition-related headwinds. For 2026, Baughman expects free cash flow of $3.5 billion to $3.6 billion, representing approximately 10% growth, and the company plans to return approximately $2.2 billion of capital to shareholders, including $1 billion in share repurchases and $1.2 billion in dividends. The dividend per share increase is $0.11, or approximately 5%, and buybacks are planned to be ratable throughout the year. These numbers matter for the stock because they put a floor under the 2026 EPS bridge: if operations add about $0.50 of EPS, the software renewal dynamic subtracts approximately $0.15, and capital return is planned at $2.2 billion, the equity story is not relying solely on a macro rebound in Europe or China.

The read-through for semiconductor customers is narrow but useful: Emerson’s Test & Measurement plan points to continued capital and engineering support for automated test customers rather than a pause. Texas Instruments TXN and Analog Devices ADI are identified customers for automated test and measurement systems, and Emerson’s Test & Measurement segment is planned to have high single-digit growth in both the first half and full year. That does not say Texas Instruments or Analog Devices orders are growing by high single digits, and we should not pretend it does. It does say that Emerson’s own planning assumption for the segment serving those customers is high single-digit growth even while Control Systems & Software faces a $110 million first-half software renewal headwind. For semiconductor PMs, the second-order implication is that the test-and-measurement portion of the supply chain is not confirming a broad freeze in analog and mixed-signal engineering spend. If that segment slips below high single-digit growth in the first half, the read-through to Texas Instruments and Analog Devices becomes materially worse; if it holds, Emerson is another datapoint against the view that semiconductor test demand is rolling over.

The peer comparison also argues against using Emerson’s top-line miss as a proxy for test-equipment weakness across the sector. In the latest Test_Assembly peer set, revenue growth ranges from -3.7% at 6125.T to +48.3% at 6871.T, with ATEYY at +43.8%, DSCSY at +12.3%, 7729.T at +13.7%, 6315.T at +22.6%, 6941.T at +43.0%, and 6140.T at +11.2%. Gross margins also vary widely, from 25.4% at 6125.T to 70.8% at DSCSY, while Emerson’s Q4 FY2025 gross margin was 51.9%. The comparative point is not that Emerson should trade like the highest-growth Japanese test names; it is that the subsector data is too dispersed to let a -0.9% Emerson revenue miss define semiconductor test demand. Emerson’s own Test & Measurement commentary is still high single-digit growth, and the peer table shows several test and assembly names with double-digit or much higher year-over-year growth, so the better inference is mix dispersion rather than cycle exhaustion.

The call delivery was less upbeat than the guide, which is the one real conflict in the data. The tone history shows Q4 FY2025 sentiment at 0.34 versus Q3 FY2025 at 0.40, guidance_tone at 0.39 versus Q3 FY2025 at 0.65, prepared_sentiment at 0.65 versus Q3 FY2025 at 0.79, and qa_sentiment at 0.07 versus Q3 FY2025 at 0.18. Uncertainty rose to 69.6 in Q4 FY2025 from 68.4 in Q3 FY2025, while ai_optimism moved to 0.82 from 0.20. That combination is unusual: the language model scores more forward optimism, but the human Q&A tone is much weaker. The right interpretation is that management was confident in the 2026 bridge but less comfortable in the live defense of the cadence, especially around renewals and regional softness. The subsequent tone table entries underline that the communication burden did not disappear, with Q2 FY2026 sentiment at 0.30, prepared_sentiment at 0.39, guidance_tone at 0.45, uncertainty at 58.7, and qa_evasiveness at -26.0.

That tonal tension should not override the numeric guide, but it does tell PMs where to press management. The company’s own reported basis on the call included adjusted earnings per share of $6 up 9% and free cash flow of $3.24 billion up 12% year-over-year, while the Street-comparison print for Q4 FY2025 was EPS of $1.62 and revenue of $4,855.0 million. Those are different bases and should not be collapsed into a single beat narrative. The investment case instead rests on whether the 2026 bridge converts: approximately 5.5% sales growth, approximately 4% underlying sales growth, approximately 2.5 points from price, approximately 27% first-quarter adjusted segment EBITDA margin, approximately 28% full-year adjusted segment EBITDA margin, and free cash flow of $3.5 billion to $3.6 billion. If the stock sells off on the -0.9% revenue miss without crediting those guide components, the mispricing is that investors are charging Emerson twice for the same renewal headwind.

What to watch next quarter is concrete. The thesis is confirmed if Q1 FY2026 lands near revenue of $4,346.0 million, gross margin of 53.2%, EPS of $1.07 on the historical table basis, and management’s call guide of adjusted earnings per share of approximately $1.40 with adjusted segment EBITDA margin of approximately 27%. The breakpoints are also clear: Test & Measurement must still be described as high single-digit growth in the first half, Control Systems & Software weakness should remain tied to the $110 million first-half renewal headwind rather than broad demand, and the full-year renewal drag should stay at $120 million, approximately $0.15 of adjusted EPS, and approximately 40 basis points of adjusted segment EBITDA margin. By the next quarterly call, any cut to 2026 adjusted earnings per share of $6.35 to $6.55, free cash flow of $3.5 billion to $3.6 billion, or the approximately 28% adjusted segment EBITDA margin target would break the view that Q4 was a mix and timing reset. If those numbers hold while Q1 revenue follows the expected seasonal step to $4,346.0 million, the market’s focus on the -0.9% revenue miss will have been too narrow.